Skip to main content

Table 4 Neonatal outcomes

From: Improved nutrient intake following implementation of the consensus standardised parenteral nutrition formulations in preterm neonates – a before-after intervention study

  Pre-consensus Post-consensus PN Group P Value
PN Group (N = 68) (N = 85)
Hypotension needing inotropic support 7 (10.3) 6 (7.1) (OR 0.66, 95% CI 0.21, 2.07) 0.476
Days of respiratory support (Mean ± SD) 34 (±35.90) 20.2 (±25.72) 0.009
CLD 19 (27.9) 13 (15.3) (OR 0.46, 95% CI 0.21, 1.02) 0.056
Sepsis (Early and late onset) 14 (20.6) 10 (11.7) (OR 0.51, 95% CI 0.21, 1.24) 0.315
PDA needing treatment 24 (35) 20 (23.5) (OR 0.56, 95% CI 0.27, 1.14) 0.277
NEC > stage II 6 (8.8) 3 (3.5) (OR 0.37, 95% CI 0.09, 1.57) 0.167
ROP stage III and above 4 (5.9) 3 (3.6) (OR 0.58, 95% CI 0.12, 2.70) 0.510
IVH > Grade II 7 (10.3) 7 (8.3) (OR 0.78, 95% CI 0.26, 2.34) 0.678
PMA at discharge/Transfer, wk 36.7 (±5.01) 34.8 (±3.76) 0.013
Discharge weight, g (Mean ± SD) 2141 (±796.24) 1978 (±672.74) 0.183
Discharge weight percentile (Mean ± SD) 12.6 (±15.28) 17.2 (±16.9) 0.016
Weight gain by 4 weeks age, g (Mean ± SD) 218.8 (±155.47) 264.9 (±234.15) 0.003
Mortality 5 (7.35) 3 (3.52) (OR 0.46, 95% CI 0.10, 2.00) 0.291
  1. Numbers (%) are given unless indicated. PMA, Postmenstrual age in weeks.